Skip to main content

BRIEF-Akers Biosciences completes clinical trial for rapid chlamydia test

* Akers Biosciences Inc says test performed well, with 96 percent correlation to gold standard reference laboratory method
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.